Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rohto Pharmaceutical Europe is the regional subsidiary of Rohto Pharmaceutical Co., Ltd., a global leader in consumer healthcare, ophthalmology, and regenerative medicine. The company is responsible for the distribution and marketing of Rohto's diverse portfolio, including the MediLuxe line of medical-grade skincare and the renowned V-Rohto eye care products. Beyond its established consumer brands, Rohto is a significant player in the biotechnology space, focusing on the development of mesenchymal stem cell (MSC) therapies for unmet medical needs such as liver cirrhosis and heart failure. Headquartered in the Netherlands, Rohto Pharmaceutical Europe serves as the strategic center for the group's expansion into the European market, managing regulatory affairs and commercial partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rohto MediLuxe Europe.